SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,134,926 | $3,375,000 | 3.69% |
| Aisling Capital Management LP | 10,100,000 | $4,190,000 | 1.82% |
| Samsara BioCapital, LLC | 5,938,215 | $2,464,000 | 1.42% |
| Corriente Advisors, LLC | 3,021,692 | $1,254,000 | 1.35% |
| MPM BioImpact LLC | 2,809,912 | $1,166,000 | 0.71% |
| Burrage Capital Management LLC | 682,586 | $280,000 | 0.28% |
| Avidity Partners Management LP | 4,310,000 | $1,788,000 | 0.25% |
| BVF INC/IL | 6,194,925 | $2,570,000 | 0.24% |
| Nantahala Capital Management | 9,566,844 | $3,969,000 | 0.15% |
| Worth Venture Partners, LLC | 362,330 | $150,000 | 0.09% |